Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
CRYPTO
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
TECHNOLOGY
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
MARKETS
Insider Trading Alert - EAT, NAVB And INTC Traded By Insiders
By TheStreet Wire
Nov 5, 2015 12:45 PM EST
PRESS RELEASES
Navidea Biopharmaceuticals To Present At The H.C. Wainwright Global Life Sciences Virtual Conference
By Business Wire
Mar 2, 2021 4:01 PM EST
PRESS RELEASES
Navidea Biopharmaceuticals Announces $5 Million Private Placement With Existing Investor
By Business Wire
Mar 2, 2021 7:30 AM EST
PRESS RELEASES
Navidea Biopharmaceuticals Announces Submission Of Formal Type B Meeting Request With FDA And Launch Of NAV3-32 Phase 2B Trial In Rheumatoid Arthritis
By Business Wire
Feb 8, 2021 4:05 PM EST
PRESS RELEASES
Navidea Biopharmaceuticals To Present At The 2021 ICR Conference On January 14, 2021
By Business Wire
Jan 7, 2021 7:30 AM EST
PRESS RELEASES
Navidea Biopharmaceuticals Strengthens Board Of Directors With The Appointment Of Malcolm Witter
By Business Wire
Dec 28, 2020 7:30 AM EST
PRESS RELEASES
Navidea Biopharmaceuticals Announces Positive Results Encompassing Additional Patients From Its Ongoing Phase 2B Study In Rheumatoid Arthritis
By Business Wire
Nov 12, 2020 4:01 PM EST
PRESS RELEASES
Navidea Biopharmaceuticals To Host Third Quarter 2020 Earnings Conference Call And Corporate Update
By Business Wire
Nov 5, 2020 4:01 PM EST
PRESS RELEASES
Navidea Biopharmaceuticals To Present At The Virtual Investor KOL Roundtable
By Business Wire
Oct 22, 2020 7:30 AM EDT
PRESS RELEASES
Navidea Biopharmaceuticals Announces Acceptance Of Abstract For Presentation At The American College Of Rheumatology Annual Meeting
By Business Wire
Oct 9, 2020 7:30 AM EDT
PRESS RELEASES
Navidea Biopharmaceuticals To Ring Opening Bell At The New York Stock Exchange
By Business Wire
Sep 28, 2020 7:30 AM EDT
PRESS RELEASES
Navidea Biopharmaceuticals To Present At H.C. Wainwright 22nd Annual Global Investment Conference
By Business Wire
Sep 8, 2020 4:05 PM EDT
PRESS RELEASES
Navidea Biopharmaceuticals Wins Dismissal Of Platinum Loan Litigation
By Business Wire
Sep 2, 2020 4:05 PM EDT
PRESS RELEASES
Navidea Biopharmaceuticals To Present At The LD 500 Virtual Investor Conference
By Business Wire
Aug 24, 2020 4:05 PM EDT
PRESS RELEASES
Jubilant Radiopharma And Navidea Biopharmaceuticals Sign Binding Memorandum Of Understanding For Commercialization Partnership
By Business Wire
Aug 10, 2020 9:08 AM EDT
PRESS RELEASES
Navidea Biopharmaceuticals Signs Binding Framework For Commercialization Partnership With Jubilant Radiopharma
By Business Wire
Aug 10, 2020 7:30 AM EDT
PRESS RELEASES
Navidea Biopharmaceuticals To Host Second Quarter 2020 Earnings Conference Call And Corporate Update
By Business Wire
Aug 6, 2020 4:15 PM EDT
PRESS RELEASES
Navidea Biopharmaceuticals Announces Full Enrollment In Its Ongoing Phase 2B Trial Of Tc99m Tilmanocept In Rheumatoid Arthritis (RA)
By GlobeNewswire
Jun 15, 2020 8:00 AM EDT
PRESS RELEASES
Navidea Biopharmaceuticals To Present At The Virtual Investor Fireside Chat Series
By GlobeNewswire
Jun 9, 2020 7:30 AM EDT
PRESS RELEASES
Navidea Biopharmaceuticals Announces Acceptance Of Abstract For Presentation At The European League Against Rheumatism (EULAR) Congress
By GlobeNewswire
Jun 3, 2020 7:30 AM EDT
PRESS RELEASES
Navidea Biopharmaceuticals Regains Commercialization And Distributions Rights In Europe For LYMPHOSEEK®
By Business Wire
May 11, 2020 7:30 AM EDT
PRESS RELEASES
Navidea Biopharmaceuticals To Host First Quarter 2020 Earnings Conference Call And Corporate Update
By Business Wire
May 7, 2020 7:00 AM EDT
PRESS RELEASES
Navidea Biopharmaceuticals Provides Statement Regarding COVID-19 Pandemic
By Business Wire
Apr 22, 2020 7:30 AM EDT
PRESS RELEASES
Navidea Biopharmaceuticals Signs Letter Of Intent With WorldCare Clinical To Partner On Navidea's Rheumatoid Arthritis Clinical Imaging Workflow And Commercialization; Other Business Updates
By Business Wire
Mar 31, 2020 7:30 AM EDT
PRESS RELEASES
Navidea Biopharmaceuticals Announces Issuance Of Patent Extension For Lymphoseek®
By Business Wire
Mar 20, 2020 7:00 AM EDT
